| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 17,980 | 20,533 | 15,499 | 17,608 | | Cost of Revenue | 14,220 | 14,629 | 12,898 | (13,876) | | | Gross Profit | 3,760 | 5,904 | 2,602 | 31,485 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 744 | 854 | 899 | 28,639 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,152 | 2,085 | 1,911 | 1,569 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 863 | 2,964 | (208) | 1,277 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 275 | 324 | 250 | (968) | | Earnings Before Interest And Taxes | 980 | 3,165 | 153 | 96 | | Interest Expense | 2,547 | 2,584 | 2,001 | 2,001 | | Income Before Tax | (1,567) | 581 | (1,848) | (1,905) | | Income Tax Expense | (502) | 371 | (896) | (466) | | Minority Interest | 372 | (73) | 333 | 504 | | | | Net Income From Continuing Ops | (693) | 136 | (619) | (936) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (693) | 136 | (619) | (936) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($693) | $136 | ($619) | ($936) |
|
0.02% Nasdaq 
0.33%
Income Statement
